Watson CH
Gsell PS
Hall Y
Camacho A
Riveros X
Enwere G
Vicari A
Nadlaou SD
Toure A
Sani IM
Diallo A
Kolie C
Duraffour S
Ifono K
Maomou A
Dore K
Djidonou HA
Bagayoko A
Damey PP
Camara MN
Diallo FB
Oumar FT
Toure K
Diaby ML
Sylla L
Conde D
Kaba IL
Tipton T
Eggo RM
Marks M
Roberts CH
Strecker T
Günther S
Keita S
Edmunds WJ
Carroll MW
Henao-Restrepo AM
BMC medicine 2024 Nov 07; 22(1); . doi: 10.1186/s12916-024-03726-z. Epub 2024 11 07
Cohort study
Ebola
Ebola virus disease
Immunogenicity
RVSV-ZEBOV
Safety
Vaccine